Compare · CTSH vs IQV
CTSH vs IQV
Side-by-side comparison of Cognizant Technology Solutions Corporation (CTSH) and IQVIA Holdings Inc. (IQV): market cap, price performance, sector, and recent activity on the wire.
Summary
- CTSH operates in Technology, while IQV operates in Health Care - the two are in different parts of the market.
- IQV is the larger of the two at $44.09B, about 1.7x CTSH ($26.64B).
- Over the past year, CTSH is down 12.6% and IQV is up 53.7% - IQV leads by 66.4 points.
- CTSH has been more active in the news (27 items in the past 4 weeks vs 6 for IQV).
- Both have 25 recent analyst ratings on file.
- Company
- Cognizant Technology Solutions Corporation
- IQVIA Holdings Inc.
- Price
- $58.23+1.82%
- $271.72-1.21%
- Market cap
- $26.64B
- $44.09B
- 1M return
- -6.18%
- +3.88%
- 1Y return
- -12.65%
- +53.71%
- Industry
- EDP Services
- Biotechnology: Commercial Physical & Biological Resarch
- Exchange
- NASDAQ
- NYSE
- IPO
- 1998
- 2013
- News (4w)
- 27
- 6
- Recent ratings
- 25
- 25
Cognizant Technology Solutions Corporation
Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. The company operates through four segments: Financial Services; Healthcare; Products and Resources; and Communications, Media and Technology. It offers customer experience enhancement, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; and enhanced compliance, integrated health management, claims investigative services, and patient experience, as well as services that drive operational improvements in areas, such as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies. The company also provides solution to manufacturers, retailers and travel and hospitality companies, as well as companies providing logistics, energy and utility services; and cloud, interactive, and IoT services to information, media and entertainment, and communications and technology companies. Cognizant Technology Solutions Corporation was founded in 1994 and is headquartered in Teaneck, New Jersey.
IQVIA Holdings Inc.
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Latest CTSH
- Cognizant and Cognition put autonomous AI engineering into production at Odyssey Logistics, with a 37 percent net cost saving
- Belcan, a Cognizant company, Recognized as a 2025 PPG Excellent Supplier
- President - Americas Gummadi Surya converted options into 1,995 shares and covered exercise/tax liability with 988 shares, increasing direct ownership by 3% to 40,820 units (SEC Form 4)
- CLO, CAO & Corporate Secretary Kim John Sunshin converted options into 1,647 shares and covered exercise/tax liability with 889 shares, increasing direct ownership by 2% to 40,667 units (SEC Form 4)
- President - APJ and ISG Ayyar Balu Ganesh converted options into 849 shares, increasing direct ownership by 0.74% to 115,079 units (SEC Form 4)
- SVP, Controller & CAO Kerdman Alina converted options into 200 shares and covered exercise/tax liability with 66 shares, increasing direct ownership by 12% to 1,263 units (SEC Form 4)
- Chief Executive Officer Singisetti Ravi Kumar converted options into 5,987 shares and covered exercise/tax liability with 3,231 shares, increasing direct ownership by 2% to 132,319 units (SEC Form 4)
- Chief People Officer Diaz Kathryn converted options into 749 shares and covered exercise/tax liability with 373 shares, increasing direct ownership by 2% to 24,086 units (SEC Form 4)
- Chief Financial Officer Dalal Jatin P converted options into 2,494 shares and covered exercise/tax liability with 1,347 shares, increasing direct ownership by 2% to 50,202 units (SEC Form 4)
- President Operations CMD India Varrier Rajesh covered exercise/tax liability with 468 shares and converted options into 1,270 shares, increasing direct ownership by 8% to 11,264 units (SEC Form 4)
Latest IQV
- IQVIA Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
- SEC Form 8-K filed by IQVIA Holdings Inc.
- IQVIA Announces Pricing of Senior Notes
- IQVIA Announces Offering of Senior Notes
- Officer Berkshire James G. exercised 5,381 shares at a strike of $131.82, sold $697,228 worth of shares (2,668 units at $261.33) and returned $709,558 worth of shares to the company (2,713 units at $261.54) (SEC Form 4)
- IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster
- IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare
- IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year
- IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group
- Officer Staub W Richard sold $1,279,740 worth of shares (5,500 units at $232.68), decreasing direct ownership by 29% to 13,312 units (SEC Form 4)